New nasal spray offers hope for depression that Won't quit

NCT ID NCT05660642

Recruiting now Disease control Sponsor: Beckley Psytech Limited Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental nasal spray called BPL-003, given with psychological support, for people with treatment-resistant depression. It aims to see if the spray is safe and how it affects the brain in 64 participants whose depression hasn't improved with at least two standard medications. The research will test one or two doses of the spray, either alone or alongside certain antidepressants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hammersmith Medicines Research
RECRUITING

London, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
King's College London, Clinical Trials Facility
COMPLETED

London, United Kingdom
MAC Clinical Research
RECRUITING

Liverpool, L34 1BH, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TREATMENT RESISTANT DEPRESSION